Baby botulism outbreak: FDA still doesn't know cause—or how to prevent it
Summary
Ars Technica reports on a baby botulism outbreak linked to ByHeart infant formula and the ongoing uncertainty about its cause and prevention. The FDA’s Post-Outbreak Response Activities detail that while contamination was traced to milk powders and ingredients from multiple suppliers, the exact entry point remains unknown, prompting finger-pointing among involved companies and critics urging clearer guidance and safer testing protocols. The piece highlights regulatory accountability, litigation, and the broader implications for infant food safety.